WHY ACCELERATE?
of children with cancer resistant to conventional treatment die
of delay until the same new medicine already approved for adults gets approved for children
long-term survivors of childhood cancer live in Europe today. 2/3 of them experience long-term health related problems
LATEST UPDATES
ACCELERATE's goal is to make research go further, faster.
Key Challenge
Although paediatric cancer survival has improved over the past decades, it remains the leading disease-related cause of death in children. For survivors, long term toxicities are still too frequent and severe.
Critical Gap
Therapies approved for adults often take years before being available to children.
How to Move Forward
Bring all stakeholders together to identify problems, research and develop recommendations and solutions in a neutral, inclusive platform: this is ACCELERATE.
